COVID-19

  • Still Bracing for the Surge in Advanced Cancer Cases

    Still Bracing for the Surge in Advanced Cancer Cases

    The predicted wave of late-stage cancers is taking longer to materialize than we expected.

    Read Article
  • The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.

    Listen to Podcast
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?

    Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?

    Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. Have the rules of the game changed?

    Listen to Podcast
  • A now-or-never moment for telehealth?

    A now-or-never moment for telehealth?

    Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.

    Read External Article
  • Let's Go
  • Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Read External Article
  • A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.

    Watch Video
  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.

    Watch Webinar
  • The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

    Watch Video
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • COVID-19 Resources for Providers and Health Plans

    COVID-19 Resources for Providers and Health Plans

    A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

    Read Article
  • loading
    Loading More...